Evidence map›Paper›PMID 20643780›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

Volumes to learn: advancing therapeutics with innovative computed tomography image data analysis.

Michael L Maitland

Abstract readComment
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2011
    Trial
  3. Article
  4. Article
  5. Article
  6. Overview: progression-free survival as an endpoint in clinical trials with solid tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Review
  7. Review
  8. Clinical trials in the era of personalized oncology.CA: a cancer journal for clinicians
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Michael L MaitlandThe University of Chicago Medical Center, Chicago, Department of Medicine, Section of Hematology/Oncology,Committee on Clinical Pharmacology and Pharmacogenomics, MC2115, 5841 South Maryland Avenue, Chicago, IL 60637, USA. mmaitlan@medicine.bsd.uchicago.edu

Funding

Translational Medicine and Cancer Therapy with Vasculature-Targeted AgentsK23CA124802 · NCI · UNIVERSITY OF CHICAGO · PI MAITLAND, MICHAEL L. · 2007 to 2011
$649k
NCI NIH HHS K23 CA124802
6 · The paper itself

Abstract

Semi-automated methods for calculating tumor volumes from computed tomography images are a new tool for advancing the development of cancer therapeutics. Volumetric measurements, relying on already widely available standard clinical imaging techniques, could shorten the observation intervals needed to identify cohorts of patients sensitive or resistant to treatment.

Indexed as

Tumor BurdenCarcinoma, Non-Small-Cell LungCone-Beam Computed TomographyHumansImage Processing, Computer-AssistedLearningLung NeoplasmsModels, BiologicalPattern Recognition, Automated

Identifiers

PMID20643780
PMCPMC3263311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.